Hepatitis B hos børn

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Hepatitis B hos børn. / Christensen, Vibeke Brix; Nordly, Sannie Brit; Kjær, Mette; Jørgensen, Marianne Hørby.

In: Ugeskrift for Laeger, Vol. 176, No. 8, V02130135, 14.04.2014, p. 726-729.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Christensen, VB, Nordly, SB, Kjær, M & Jørgensen, MH 2014, 'Hepatitis B hos børn', Ugeskrift for Laeger, vol. 176, no. 8, V02130135, pp. 726-729.

APA

Christensen, V. B., Nordly, S. B., Kjær, M., & Jørgensen, M. H. (2014). Hepatitis B hos børn. Ugeskrift for Laeger, 176(8), 726-729. [V02130135].

Vancouver

Christensen VB, Nordly SB, Kjær M, Jørgensen MH. Hepatitis B hos børn. Ugeskrift for Laeger. 2014 Apr 14;176(8):726-729. V02130135.

Author

Christensen, Vibeke Brix ; Nordly, Sannie Brit ; Kjær, Mette ; Jørgensen, Marianne Hørby. / Hepatitis B hos børn. In: Ugeskrift for Laeger. 2014 ; Vol. 176, No. 8. pp. 726-729.

Bibtex

@article{0eb357f7dc2c43cebfd540f26dab9046,
title = "Hepatitis B hos b{\o}rn",
abstract = "Chronic hepatitis B (HBV) infection is seen in 400 million persons worldwide. HBV is transmitted vertically or horizontally by infected blood and body fluids. An effective vaccine exists. Most children develop a chronic HBV infection if infected early in life. They are often in an immune-tolerant phase with no indication for antiviral treatment. Antiviral treatment with interferon or a nucleotide analogue is a possibility if the HBV infected child develops into a phase of immune activation. HBV infection can lead to liver cirrhosis and hepatocellular carcinoma.",
author = "Christensen, {Vibeke Brix} and Nordly, {Sannie Brit} and Mette Kj{\ae}r and J{\o}rgensen, {Marianne H{\o}rby}",
year = "2014",
month = apr,
day = "14",
language = "Dansk",
volume = "176",
pages = "726--729",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "8",

}

RIS

TY - JOUR

T1 - Hepatitis B hos børn

AU - Christensen, Vibeke Brix

AU - Nordly, Sannie Brit

AU - Kjær, Mette

AU - Jørgensen, Marianne Hørby

PY - 2014/4/14

Y1 - 2014/4/14

N2 - Chronic hepatitis B (HBV) infection is seen in 400 million persons worldwide. HBV is transmitted vertically or horizontally by infected blood and body fluids. An effective vaccine exists. Most children develop a chronic HBV infection if infected early in life. They are often in an immune-tolerant phase with no indication for antiviral treatment. Antiviral treatment with interferon or a nucleotide analogue is a possibility if the HBV infected child develops into a phase of immune activation. HBV infection can lead to liver cirrhosis and hepatocellular carcinoma.

AB - Chronic hepatitis B (HBV) infection is seen in 400 million persons worldwide. HBV is transmitted vertically or horizontally by infected blood and body fluids. An effective vaccine exists. Most children develop a chronic HBV infection if infected early in life. They are often in an immune-tolerant phase with no indication for antiviral treatment. Antiviral treatment with interferon or a nucleotide analogue is a possibility if the HBV infected child develops into a phase of immune activation. HBV infection can lead to liver cirrhosis and hepatocellular carcinoma.

M3 - Tidsskriftartikel

C2 - 25096461

VL - 176

SP - 726

EP - 729

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 8

M1 - V02130135

ER -

ID: 137661421